心房細動患者におけるカテーテルを用いた心臓弁置換術後のエドキサバンと標準治療の比較（ENVISAGE-TAVI AF）

基本情報

NCT ID

NCT02943785

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

1,426

治験依頼者名

Daiichi Sankyo

概要

When the upper chambers of a person's heart receive or generate irregular electrical signals, it causes abnormal rhythm in the heartbeat. This is called atrial fibrillation. Atrial fibrillation goes along with blood clots that may cause mainly strokes and less often other diseases, such as a heart attack. Some patients with atrial fibrillation have other heart disease, such as heart valves that may need to be replaced using catheters. Often doctors give patients drugs that reduce those blood clots. These are either vitamin K antagonist (VKA) or direct anticoagulants, such as edoxaban. In these patients, it is unclear which of the drugs is better for reducing stroke without increasing severe bleedings.

対象疾患

介入

依頼者（Sponsor）

実施施設 (18)